Sustainable growth

Alcon has completed its separation from Novartis

Colin Kerr

Posted: Saturday, June 1, 2019

Alcon has completed its separation from Novartis and the company’s shares are now trading on the SIX Swiss Exchange and New York Stock Exchange (NYSE) under the symbol “ALC.”

“For more than 70 years, Alcon has been dedicated to helping people see brilliantly and now, as an independent company, we are pursuing even more opportunities to further that mission,” said David Endicott, Chief Executive Officer of Alcon. “We are poised to achieve sustainable growth and create long-term shareholder value as a standalone company. As a nimble medical device company, we are sharply focused on providing innovative products that meet the needs of our customers, patients and consumers.”